ETRASIMOD

etrasimod 2 mg tablet, 28

ETRASIMOD (14601L)

etrasimod 2 mg tablet, 28
14601L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: Continuing treatment

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: Continuing treatment - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 5 DPMQ: $1,434.40 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Velsipity